- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025
- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025

IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Congress map
Accreditation

GO BACK

IMCAS Academy International
Program

Adapt the schedule of the livestreamed class/congress to your time zone

Time zone reference: (UTC-04:00) America, New York

Time zone

Time zone:Change time zone

If you are logged in, change your default time zone in your account

COSMECEUTICALS UPDATES – MELASMA, ASIAN SKIN AND EXOSOMES

Focus program

Room: Webinar
Date: Tuesday 20 September 2022 at 11:00 to 12:30
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chair

Dr Sophie MENKES

Switzerland

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
11:00	Dominique DU CREST	Moderator		117433
11:00		Introduction		118680
11:05	Dr Sabine ZENKER	Topical cosmeceutical actives for melasma	View	117437
11:20	Dr Maya Minjin OH	Cosmeceuticals for Asian skin	View	117435
11:35	Dr Arnaud LAMBERT	Exosomes for skin rejuvenation : where are we now?		117434
11:50		Question & Answer with the audience		117439

Go to previous day (Webinar)

Go to next day (Webinar)

Dominique DU CREST

Industry Representative

France

Other author(s) :

Moderator

Introduction

Dr Sabine ZENKER

Dermatologist

Germany

Other author(s) :

Topical cosmeceutical actives for melasma

Objectives: To give an update topical on depigmentation by cosmeceuticals for melasma

Introduction: The effective and sustainably successful management of melasma is a difficult task. An advanced understanding of the pathogenesis of melasma and the signaling routs of melanogenesis is required. Topicals such as cosmeceuticals can play an important role not only as pre- and post-treatment tools, but can also -and certainly in combination protocols- serve as effective in-clinic treatment options.

Materials / method: In melasma, hyperactive melanocytes not only overproduce melanin but they also accumulate melanin resulting in unwanted hyperpigmentation and dermatological diseases such as melasma. Complex scientific data shows today that there are several signaling pathways by which different cell types upregulate or downregulate melanogenesis. But also that there are other contributors to this unwanted skin discoloration such as e.g. new vessel formation, inflammation and oxidation etc..

Results: Therefore, modern concepts of treating melasma topically must target all the various and different pathway causing this diseases. Even with cosmeceuticals ‘only’ one can be quite effective and be on the safe side, especially in treating light melasma or in managing recurrent melasma on the long term.

Conclusion: Modern concepts for treating melasma topically have to target all the various and different pathways causing this disease. This said, cosmeceuticals are an indispensable tool especially to be combined in e.g. pre- and post-procedure protocols but can be very useful also in treating especially light melasma or in managing recurrent melasma on the long term.

Dr Sabine Zenker, Munich, September 7th, 2022

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Maya Minjin OH

Cosmetic Surgeon

South Korea

Other author(s) :

Cosmeceuticals for Asian skin

Objectives: Cosmeceuticals for Asian Skin

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Arnaud LAMBERT

France

Other author(s) :

Exosomes for skin rejuvenation : where are we now?

Question & Answer with the audience

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Asia
IMCAS China
IMCAS World Congress
IMCAS Americas
IMCAS Asia

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Academy International Program

COSMECEUTICALS UPDATES – MELASMA, ASIAN SKIN AND EXOSOMES

Chair

Lectures of the session

IMCAS Academy International
Program